GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback